Novo Nordisk shares shoot up amid promising results for anti-obesity pill
Market value of drugmaker climbs by £6.5bn as trial shows ‘significant weight loss’ for pill version of WegovyBusiness live – latest updatesThe value of the drugmaker Novo Nordisk has shot up by more than £6.5bn after research showed its new anti-obesi…